{
  "id": 14726868,
  "title": "Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders",
  "url": "https://urgent.news/2026/10/15/forget-cystic-fibrosis-vertexs-next-growth-engine-could-be-hormone-14726868",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-15T15:01:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/forget-cystic-fibrosis-vertexs-next-growth-engine-could-be-hormone-disorders"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThanks to its most recent acquisition, Vertex now has some promising products in the field of hormone disorders.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders",
        "url": "https://urgent.news/2026/10/15/forget-cystic-fibrosis-vertexs-next-growth-engine-could-be-hormone",
        "published": "2026-10-15T14:41:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}